Current Edition

chemotherapy

UK trial assessing AZ’ AZD1775 in head and neck cancer

A clinical trial testing AstraZeneca’s experimental drug AZD1775, an inhibitor of the cell cycle regulating protein WEE1, in patients with head and neck cancer has …

Continue Reading →